Northwestern Mutual Wealth Management CO Vaneck ETF Tr Vaneck Pharmaceu Transaction History

Northwestern Mutual Wealth Management CO

$112 Billion
Q3 2024

A detailed history of Northwestern Mutual Wealth Management CO transactions in Vaneck ETF Tr Vaneck Pharmaceu stock. As of the latest transaction made, Northwestern Mutual Wealth Management CO holds 161,688 shares of PPH stock, worth $14 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares

161,688

Previous 160,039 1.03%

Holding current value

$14 Million

Previous $14.6 Million 4.95%

% of portfolio

0.01%

Previous 0.01%

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 12, 2024	BUY	$90.59 - $99.43 $149,382 - $163,960	1,649 Added 1.03%	161,688 $15.4 Million
Q2 2024 Aug 15, 2024	BUY	$84.87 - $93.23 $228,639 - $251,161	2,694 Added 1.71%	160,039 $14.6 Million
Q1 2024 May 15, 2024	BUY	$82.63 - $90.89 $605,430 - $665,951	7,327 Added 4.88%	157,345 $14.3 Million
Q4 2023 Feb 13, 2024	SELL	$74.32 - $81.37 $223,405 - $244,598	-3,006 Reduced 1.96%	150,018 $12.2 Million
Q3 2023 Nov 14, 2023	BUY	$76.26 - $83.18 $11.6 Million - $12.7 Million	152,143 Added 17269.35%	153,024 $12.2 Million
Q2 2023 Aug 14, 2023	BUY	$75.02 - $80.55 $33,909 - $36,408	452 Added 105.36%	881 $69,000
Q1 2023 May 15, 2023	SELL	$73.68 - $79.63 $147 - $159	-2 Reduced 0.46%	429 $33,000
Q4 2022 Feb 21, 2023	BUY	$67.31 - $79.26 $29,010 - $34,161	431 New	431 $33,000

Others Institutions Holding PPH

# of Institutions

147

Shares Held

5.83M

Call Options Held

12.6K

Put Options Held

7.3K

View Full List

About VANECK ETF TR VANECK PHARMACEU

Ticker PPH
Sector ETFs
Industry ETFs

More about PPH

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Northwestern Mutual Wealth Management CO, based on Form 13F filings with the SEC.

News

Stay updated on Northwestern Mutual Wealth Management CO with notifications on news.

Account

Northwestern Mutual Wealth Management CO Vaneck ETF Tr Vaneck Pharmaceu Transaction History